катехоламин对早产婴儿血流的影响:PICC-MBF试验的次分析
Akio Ishiguro1, Kazuhiko Kabe1
1Division of Neonatal Medicine, Center for Maternal, Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Neonatology
|September 3, 2023
概括
皮肤血流可以表明在非常低出生体重 (VLBW) 婴儿的全身血流. 这项研究还发现多巴胺和多布胺如何影响这些婴儿的血液循环的差异.
科学领域:
- 新生儿生理学 新生儿生理学
- 心血管研究的心血管研究.
- 儿科重症监护 儿科重症监护
背景情况:
- 评估非常低出生体重 (VLBW) 婴儿的全身血流对于临床管理至关重要.
- 对于监测VLBW婴儿血液循环的非侵入性方法是非常可取的.
- 多巴胺和多布他胺是常用的内类药物,具有明显的血液动力学效应.
研究的目的:
- 评估VLBW婴儿皮肤血流和全身血流之间的相关性.
- 为了确定皮肤血流是否可以作为系统循环的替代标记.
- 为了区分多巴胺和多布胺在VLBW婴儿的循环效应.
主要方法:
- 涉及234名VLBW婴儿的PICC-MBF随机对照试验的细分分析.
- 皮肤血液流量 (通过激光多普勒测量) 和心声学参数 (腔流量) 之间的相关性分析.
- 接收器操作者特征分析,以确定检测改变系统流量的值;在注射异能药物之前和之后评估血液动力学变化.
主要成果:
- 皮肤血液流量与上静脉流量有显著的相关性 (r = 0.31,p < 0.001).
- 皮肤血液流量<17毫升/分钟,精确识别上静脉腔流量<41毫升/分钟 (AUC = 0.83,p <0.001).
- 多布他胺增加了皮肤的血液流动而没有改变血压,而多巴胺增加了皮肤的血液流动和血压.
结论:
- 皮肤血流是VLBW婴儿系统血流的可靠替代标志物.
- 多巴胺和多布他胺对VLBW婴儿的血液循环产生不同的影响.
- 这些发现支持在新生儿重症监护机构使用皮肤血流监测.
相关概念视频
Adrenergic Agonists: Therapeutic Classification
859
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
859
Adrenergic Agonists: Therapeutic Uses
840
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
840
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
889
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
889
Adrenergic Agonists: Direct-Acting Agents
1.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.6K
Autoregulation of Blood Flow
2.4K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.4K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K


